p38 mitogen-activated protein kinase contributes to cell cycle regulation by cAMP in FRTL-5 thyroid cells

European Journal of Endocrinology

Volumn 153, Issue 1, 2005, Pages 123-133

  Correze C ^a   Blondeau, J P ^a   Pomérance, Martine ^a  

^a UNIVERSITÉ PARIS SACLAY   (France)

Author keywords

[No Author keywords available]

Indexed keywords

4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; 4 ETHYL 2 (4 METHOXYPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; CYCLIC AMP; CYCLIN DEPENDENT KINASE 2; CYCLIN E; DNA; FORSKOLIN; INSULIN; ISOENZYME; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; PROTEIN KINASE B; PROTEIN P21; PROTEIN P27; PROTEIN P70; PROTEIN TYROSINE PHOSPHATASE; REGULATOR PROTEIN; S6 KINASE; SYNAPTOPHYSIN; THREONINE; THYMIDINE; TRITIUM; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL CYCLE; CELL PROLIFERATION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DNA SYNTHESIS; DRUG ACTIVITY; ENZYME ACTIVITY; ENZYME ASSAY; ENZYME INHIBITION; ENZYME LOCALIZATION; ENZYME PHOSPHORYLATION; FLUORESCENCE ACTIVATED CELL SORTING; IMMUNOPRECIPITATION; IN VITRO STUDY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; THYROID CELL; WESTERN BLOTTING;

ANIMALS; CDC2-CDC28 KINASES; CELLS, CULTURED; CYCLIC AMP; CYCLIN-DEPENDENT KINASE 2; ENZYME INHIBITORS; FORSKOLIN; G1 PHASE; HYPOGLYCEMIC AGENTS; IMIDAZOLES; INSULIN; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHORYLATION; PYRIDINES; RATS; S PHASE; SIGNAL TRANSDUCTION; THREONINE; THYROID GLAND; TYROSINE;

EID: 22744447002     PISSN: 08044643     EISSN: None     Source Type: Journal    
DOI: 10.1530/eje.1.01942     Document Type: Article

References (48)

1. Grana X & Premkumar R. Cell cycle control in mammalian cells: role of cyclins, cyclin dependent kinases (CDKs), growth suppressor genes and cyclin-dependent kinase inhibitors (CKIs). Oncogene 1995 11 211-219.
2. Lees E. Cyclin dependent kinase regulation. Current Opinion in Cell Biology 1995 7 773-780.
3. Cheng M, Olivier P, Diehl JA, Fero M, Roussel MF, Roberts JM & Sherr CJ. The p21(Cip1) and p27(Kip1) CDK 'inhibitors' are essential activators of cyclin D-dependent kinases in murine fibroblasts. EMBO Journal 1999 18 1571-1583.
4. Medina DL & Santisteban P. Thyrotropin-dependent proliferation of in vitro rat thyroid cell systems. European Journal of Endocrinology 2000 143 161-178.
5. Kimura T, Van Keymeulen A, Golstein J, Fusco A, Dumont JE & Roger PP. Regulation of thyroid cell proliferation by TSH and other factors: a critical evaluation of in vitro models. Endocrine Reviews 2001 22 631-656.
6. Lewis A, Fikaris AJ, Prendergast GV & Meinkoth JL. Thyrotropin and serum regulate thyroid cell proliferation through differential effects on p27 expression and localization. Molecular Endocrinology 2004 18 2321-2332.
7. Cass LA & Meinkoth JL. Differential effects of cyclic adenosine 3′,5′-monophosphate on p70 ribosomal S6 kinase. Endocrinology 1998 139 1191-1998.
8. Dremier S, Pohl V, Poteet-Smith C, Roger PP, Corbin J, Doskeland SO, Dumont JE & Maenhaut C. Activation of cyclic AMP-dependent kinase is required but may not be sufficient to mimic cyclic AMP-dependent DNA synthesis and thyroglobulin expression in dog thyroid cells. Molecular and Cellular Biology 1997 17 6717-6726.
9. Cass LA, Summers SA, Prendergast GV, Backer JM, Birnbaum MJ & Meinkoth JL. Protein kinase A-dependent and -independent signaling pathways contribute to cyclic AMP-stimulated proliferation. Molecular and Cellular Biology 1999 19 5882-5891.
10. Kupperman F, Wen W & Meinkoth JL. Inhibition of thyrotropin-stimulated DNA synthesis by microinjection of inhibitors of cellular Ras and cyclic AMP-dependent protein kinase. Molecular and Cellular Biology 1993 13 4477-4484.
11. Corrèze C, Blondeau JP & Pomérance M. The thyrotropin receptor is not involved in the activation of p42/p44 mitogen-activated protein kinases by thyrotropin preparations in Chinese hamster ovary cells expressing the human thyrotropin receptor. Thyroid 2000 10 747-752.
12. Van Keymeulen A, Roger PP, Dumont JE & Dremier S. TSH and cAMP do not signal mitogenesis through Ras activation. Biochemical and Biophysical Research Communications 2000 273 154-158.
13. Coulonval K, Vandeput F, Stein RC, Kozma SC, Lamy F & Dumont JE. Phosphatidylinositol 3-kinase, protein kinase B and ribosomal S6 kinases in the stimulation of thyroid epithelial cell proliferation by cAMP and growth factors in the presence of insulin. Biochemical Journal 2000 348 351-358.
14. Saito J, Kohn AD, Roth RA, Noguchi Y, Tatsumo I, Hirai A, Suzuki K, Kohn LD, Saji M & Ringel MD. Regulation of FRTL-5 thyroid cell growth by phosphatidylinositol (OH) 3 kinase-dependent Akt-mediated signaling. Thyroid 2001 11 339-351.
15. Ciullo I, Diez-Roux G, Di Domenico M, Migliaccio A & Avvedimento EV. cAMP signaling selectively influences Ras effectors pathways. Oncogene 2001 20 1186-1192.
16. Pomérance M, Abdullah HB, Kamerji S, Corrèze C & Blondeau JP. Thyroid-stimulating hormone and cyclic AMP activate p38 mitogen-activated protein kinase cascade. Involvement of protein kinase A, rac1, and reactive oxygen species. Journal of Biological Chemistry 2000 275 40539-40546.
17. Vandeput F, Perpete S, Coulonval K, Lamy F & Dumont JE. Role of the different mitogen-activated protein kinase subfamilies in the stimulation of dog and human thyroid epithelial cell proliferation by cyclic adenosine 5′-monophosphate and growth factors. Endocrinology 2003 144 1341-1349.
18. Kyriakis JM & Avruch J. Mammalian mitogen-activated protein kinase signal transduction pathways activated by stress and inflammation. Physiological Reviews 2001 81 807-869.
19. Ono K & Han J. The p38 signal transduction pathway: activation and function. Cellular Signalling 2000 12 1-13.
20. Nebreda AR & Porras A. p38 MAP kinases: beyond the stress response. Trends in Biochemical Sciences 2000 25 257-260.
21. Cuenda A, Rouse J, Doza YN, Meier R, Cohen P, Gallagher TF, Young PR & Lee JC. SB203580 is a specific inhibitor of a MAP kinase homologue which is stimulated by cellular stresses and interleukin-1. FEBS Letters 1995 364 229-233.
22. Maher P. p38 mitogen-activated protein kinase activation is required for fibroblast growth factor-2-stimulated cell proliferation but not differentiation. Journal of Biological Chemistry 1999 274 17491-17498.
23. MAPK signalling pathway to proliferation in human cultured airway smooth muscle cells is mitogen-specific. British Journal of Pharmacology 2004 142 1182-1190.
24. Rausch O & Marshall CJ. Cooperation of p38 and extracellular signal-regulated kinase mitogen-activated protein kinase pathways during granulocyte colony-stimulating factor-induced hemopoietic cell proliferation. Journal of Biological Chemistry 1999 274 4096-4105.
25. Liu RY, Fan C, Liu G, Olashaw NE & Zuckerman KS. Activation of p38 mitogen-activated protein kinase is required for tumor necrosis factor-alpha-supported proliferation of leukemia and lymphoma cell lines. Journal of Biological Chemistry 2000 275 21086-21093.
26. Yamaguchi H, Igarashi M, Hirata A, Susa S, Ohnuma H, Tominaga M, Daimon M & Kato T. Platelet-derived growth factor BB-induced p38 mitogen-activated protein kinase activation causes cell growth, but not apoptosis, in vascular smooth muscle cells. Endocrine Journal 2001 48 433-442.
27. Masamune A, Satoh M, Kikuta K, Sakai Y, Satoh A & Shimosegawa T. Inhibition of p38 mitogen-activated protein kinase blocks activation of rat pancreatic stellate cells. Journal of Pharmacology and Experimental Therapeutics 2003 304 8-14.
28. Craxton A, Shu G, Graves JD, Saklatvala J, Krebs EG & Clark EA. p38 MAPK is required for CD40-induced gene expression and proliferation in B lymphocytes. Journal of Immunology 1998 161 3225-3236.
29. Neve RM, Holbro T & Hynes NE. Distinct roles for phosphoinositide 3-kinase, mitogen-activated protein kinase and p38 MAPK in mediating cell cycle progression of breast cancer cells. Oncogene 2002 21 4567-4576.
30. Recio JA & Merlino G. Hepatocyte growth factor/scatter factor activates proliferation in melanoma cells through p38 MAPK, ATF-2 and cyclin D1. Oncogene 2002 21 1000-1008.
31. Halawani D, Mondeh R, Stanton LA & Beier F. p38 MAP kinase signaling is necessary for rat chondrosarcoma cell proliferation. Oncogene 2004 23 3726-3731.
32. Pomérance M, Carapau D, Chantoux F, Mockey M, Corrèze C, Francon J & Blondeau JP. CCAAT/enhancer-binding protein-homologous protein expression and transcriptional activity are regulated by 3′,5′-cyclic adenosine monophosphate in thyroid cells. Molecular Endocrinology 2003 17 2283-2294.
33. Lali FV, Hunt AE, Turner SJ & Foxwell BMJ. The pyridinyl imidazole inhibitor SB203580 blocks phosphoinositide-dependent protein kinase activity, protein kinase B phosphorylation, and retinoblastoma hyperphosphorylation in interleukin-2-stimulated T cells independently of p38 mitogen-activated protein kinase. Journal of Biological Chemistry 2000 275 7395-7402.
34. Davies SP, Reddy H, Caivano M & Cohen P. Specificity and mechanism of action of some commonly used protein kinase inhibitors. Biochemical Journal 2000 351 95-105.
35. Iijima Y, Laser M, Shiraishi H, Willey CD, Sundaravadivel B, Xu L, McDermott PJ & Kuppuswamy D. c-Raf/MEK/ERK pathway controls protein kinase C-mediated p70S6K activation in adult cardiac muscle cells. Journal of Biological Chemistry 2002 277 23065-23075.
36. Whitmarsh AJ, Yang SH, Su MS, Sharrocks AD & Davis RJ. Role of p38 and JNK mitogen-activated protein kinases in the activation of ternary complex factors. Molecular and Cellular Biology 1997 17 2360-2371.
37. Clerk A & Sugden PH. The p38 MAPK inhibitor, SB203580, inhibits cardiac stress-activated protein kinases/c-Jun N-terminal kinases (SAPKs/JNKs). FEBS Letters 1998 426 93-96.
38. Shklyaev SS, Namba H, Mitsutake N, Alipov G, Nagayama Y, Maeda S, Ohtsuru A, Tsubouchi H & Yamashita S. Transient activation of c-Jun NH2-terminal kinase by growth factors influences survival but not apoptosis of human thyrocytes. Thyroid 2001 11 629-636.
39. Wang XS, Diener K, Manthey CL, Wang S, Rozenzweig B, Bray J, Delaney J, Cole CN, Chan-Hui PY, Mantlo N, Lichenstein HS, Zukowski M & Yao Z. Molecular cloning and characterization of a novel p33 mitogen-activated protein kinase. Journal of Biological Chemistry 1997 272 23668-23674.
40. Moore JD, Yang JY, Truant R & Kornbluth S. Nuclear import of Cdk/cyclin complexes: identification of distinct mechanisms for import of Cdk2/cyclin E and Cdc2/cyclin B1. Journal of Cell Biology 1999 144 213-224.
41. Jackman M, Kubota Y, Den Elzen N, Hagting A & Pines J. Cyclin A- and cyclin E-Cdk complexes shuttle between the nucleus and the cytoplasm. Molecular Biology of the Cell 2002 13 1030-1045.
42. Baptist M, Lamy F, Gannon J, Hunt T, Dumont JE & Roger PP. Expression and subcellular localization of CDK2 and cdc2 kinases and their common partner cyclin A in thyroid epithelial cells: comparison of cyclic AMP-dependent and -independent cell cycles. Journal of Cellular Physiology 1996 166 256-273.
43. Keenan SM, Bellone C & Baldassare JJ. Cyclin-dependent kinase 2 nucleocytoplasmic translocation is regulated by extracellular regulated kinase. Journal of Biological Chemistry 2001 276 22404-22409.
44. Blanchard DA, Mouhamad S, Auffredou MT, Pesty A, Bertoglio J, Leca G & Vazquez A. Cdk2 associates with MAP kinase in vivo and its nuclear translocation is dependent on MAP kinase activation in IL-2-dependent Kit 225 T lymphocytes. Oncogene 2000 19 4184-4189.
45. Yang ES & Burnstein KL. Vitamin D inhibits G1 to S progression in LNCaP prostate cancer cells through p27Kip1 stabilization and Cdk2 mislocalization to the cytoplasm. Journal of Biological Chemistry 2003 278 46862-46868.
46. Hiromura K, Pippin JW, Blonski MJ, Roberts JM & Shankland SJ. The subcellular localization of cyclin dependent kinase 2 determines the fate of mesangial cells: role in apoptosis and proliferation. Oncogene 2002 21 1750-1758.
47. Chiariello M, Gomez E & Gutkind JS. Regulation of cyclin-dependent kinase (Cdk) 2 Thr-160 phosphorylation and activity by mitogen-activated protein kinase in late G1 phase. Biochemical Journal 2000 349 869-876.
48. Lents NH, Keenan SM, Bellone C & Baldassare JJ. Stimulation of the Raf/MBK/ERK cascade is necessary and sufficient for activation and Thr-160 phosphorylation of a nuclear-targeted CDK2. Journal of Biological Chemistry 2002 277 47469-47475.